Role of the MET/HGF receptor in proliferation and invasive behavior of osteosarcoma
- PMID: 12709413
- DOI: 10.1096/fj.02-0576fje
Role of the MET/HGF receptor in proliferation and invasive behavior of osteosarcoma
Abstract
Signal transduction downstream HGF receptor (MET) activation involves multiple pathways that account for mitogenesis, motility and morphogenesis in a cell type-dependent fashion. MET receptor is aberrantly expressed in almost 100% of human osteosarcomas. We analyzed the effect of the MET receptor activation in five human osteosarcoma cell lines evaluating the levels of HGF-dependent activation of MAPK and PKB/AKT as biochemical readouts of mitogenic and invasive responses, respectively. All the cell lines tested expressed high levels of the MET proto-oncogene. Four cell lines showed activation of the MAPK cascade upon HGF stimulation, suggesting that this growth factor serves a common proliferative function in osteosarcomas. Two lines showed activation of PKB/AKT that is known to be involved in migration mediated by HGF receptor. Accordingly, cell lines where MAPK cascade was activated responded to HGF with increased proliferation, while induction and inhibition of PKB/AKT activity corresponded to acquisition or block of the invasive-motile response to HGF, respectively. Both the HGF dependent responses were reverted by the specific MET inhibitor K252a. These data show that HGF activates both the mitogen and motogen machinery in osteosarcoma cells and suggest that HGF might promote their malignant behavior by concomitant activation of different pathways and biological functions.
Similar articles
-
Both hepatocyte growth factor (HGF) and stromal-derived factor-1 regulate the metastatic behavior of human rhabdomyosarcoma cells, but only HGF enhances their resistance to radiochemotherapy.Cancer Res. 2003 Nov 15;63(22):7926-35. Cancer Res. 2003. PMID: 14633723
-
The Met/HGF receptor is over-expressed in human osteosarcomas and is activated by either a paracrine or an autocrine circuit.Oncogene. 1995 Feb 16;10(4):739-49. Oncogene. 1995. PMID: 7862451
-
Hepatocyte growth factor/scatter factor-induced activation of MEK and PI3K signal pathways contributes to expression of proangiogenic cytokines interleukin-8 and vascular endothelial growth factor in head and neck squamous cell carcinoma.Cancer Res. 2001 Aug 1;61(15):5911-8. Cancer Res. 2001. PMID: 11479233
-
Molecular characteristics of HGF-SF and its role in cell motility and invasion.EXS. 1993;65:311-28. EXS. 1993. PMID: 8380739 Review.
-
HGF: a multifunctional growth factor controlling cell scattering.Int J Biochem Cell Biol. 1999 Dec;31(12):1357-62. doi: 10.1016/s1357-2725(99)00089-8. Int J Biochem Cell Biol. 1999. PMID: 10641789 Review.
Cited by
-
Receptor Tyrosine Kinases in Osteosarcoma Treatment: Which Is the Key Target?Front Oncol. 2020 Aug 28;10:1642. doi: 10.3389/fonc.2020.01642. eCollection 2020. Front Oncol. 2020. PMID: 32984034 Free PMC article. Review.
-
Inhibition of c-Met as a therapeutic strategy for esophageal adenocarcinoma.Neoplasia. 2006 Nov;8(11):949-55. doi: 10.1593/neo.06499. Neoplasia. 2006. PMID: 17132227 Free PMC article.
-
Role of the CTRP family in tumor development and progression.Oncol Lett. 2021 Oct;22(4):723. doi: 10.3892/ol.2021.12984. Epub 2021 Aug 10. Oncol Lett. 2021. PMID: 34429763 Free PMC article. Review.
-
Molecular genetics of sarcomas: applications to diagnoses and therapy.Cancer Sci. 2009 Sep;100(9):1573-80. doi: 10.1111/j.1349-7006.2009.01232.x. Epub 2009 Jun 24. Cancer Sci. 2009. PMID: 19555393 Free PMC article. Review.
-
Gangliosides as Signaling Regulators in Cancer.Int J Mol Sci. 2021 May 11;22(10):5076. doi: 10.3390/ijms22105076. Int J Mol Sci. 2021. PMID: 34064863 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous